Financials
- Financial year
- 2025
- Total assets
- €849,063
- Profit
- €132,604
- Solvency
- 29.6%
Total assets▼ 4.2%
Net result
20182025
Apotheek Schuttershof
ActiveSummary
Apotheek Schuttershof has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €251,179 and a net result of €132,604. Equity is growing by about 6% per year across the filed financial years. Its solvency ranks better than 42% of 12,672 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€849,063total assets 2025
- Staff
- 0.7 FTE
- Equity
- €251,179
- Profit
- €132,604
Turnover not published (abbreviated format)
Structure
- Parent
- Licorice · 100%
2025 accounts 11 days early1 of 2 deeds summarised
Why 88raises riskSector: Retail trade (NACE 47)lowers riskSize: 0.7 FTE, total assets €849,063Founded in 2005Figures for financial year 2025 (filed 20-07-2026)Show the evidence
Checked score
Score 2025
88
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 50% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency
55+2
equity 29.6% of total assets
Liquidity
32-13
short-term debt 56.1% · cash 9.0%
Profitability
88-6
return on assets 15.6%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.2%
12-2024: 0.2%● unchanged vs 11-2024
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.2%▼ -0.1 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026lowest value
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.2%● unchanged vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €22,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.1, compared with 1.18 in 2024, below the usual 1.5; short-term debt: 56.1% and cash: 9% of total assets), and 70.4% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 45% on solvency, 30% on liquidity, 83% on profitability and 44% on growth.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
11 days early
2024
13 days early
2023
30 days late
2022
10 days late
2021
30 days late
2020
26 days late
2019
22 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 7 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Weakest financial yearnet €132,604 ▼27.1%
- Annual accounts filedfinancial year 2024 · abbreviated…
Key points
By topic
Board & ownership
- Parent
- Licorice · 100%
Timeline
- Events
- 24
- Since
- 2007
- Next accounts
- by 31-07-2027
- 30-08-2024Annual accounts filed
- 21-12-2023Purpose · Amendment of the articles ·…
- 10-08-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 22-12-2005
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 16
- Who signs
- Each director alone
- Annual meeting
- Last Friday of June at 20:00
Key facts about Apotheek Schuttershof
- What is the company number of Apotheek Schuttershof?
- 0878.869.290. In Belgium the VAT number is the company number with BE in front: BE 0878.869.290.
- Where is Apotheek Schuttershof based?
- The registered office is at Lobbensestraat(Mes) 313, 3272 Scherpenheuvel-Zichem.Company details
- What does Apotheek Schuttershof do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Apotheek Schuttershof?
- Private limited company (BV).
- When was Apotheek Schuttershof founded?
- On 22-12-2005.
- Is Apotheek Schuttershof still active?
- Yes, Apotheek Schuttershof is an active enterprise in the KBO register.
- How many employees does Apotheek Schuttershof have?
- On average 0.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Apotheek Schuttershof?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is Apotheek Schuttershof profitable?
- In financial year 2025, Apotheek Schuttershof made a profit of €132,604.
- Where can I find the annual accounts of Apotheek Schuttershof?
- Apotheek Schuttershof filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Apotheek Schuttershof due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Apotheek Schuttershof
Parent and group
- Licorice100%
Comparable companies
- APOTHEEK VAN REETH - DEPROSTAntwerpen
- APOTHEEK DEBACKERE LEENAalter
- J-C Grace PharmacyBrussel
- APOTHEEK ANN VERPLAETSEKuurne
- VANSCHOONBEEK FARMABekkevoort
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.